SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001193125-15-322187
Filing Date
2015-09-17
Accepted
2015-09-17 12:23:44
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM F-1 (AMENDMENT NO. 4) d912889df1a.htm F-1/A 2641862
2 EX-23.1 d912889dex231.htm EX-23.1 1416
3 GRAPHIC g912889g32b53.jpg GRAPHIC 51094
4 GRAPHIC g912889g52e70.jpg GRAPHIC 117011
5 GRAPHIC g912889g67a59.jpg GRAPHIC 36576
6 GRAPHIC g912889g94d16.jpg GRAPHIC 116569
  Complete submission text file 0001193125-15-322187.txt   3086980
Mailing Address LEBERSTRASSE 20 VIENNA C4 1110
Business Address LEBERSTRASSE 20 VIENNA C4 1110 43 (0)1 740 93-0
Nabriva Therapeutics AG (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C4 | Fiscal Year End: 1231
Type: F-1/A | Act: 33 | File No.: 333-205073 | Film No.: 151111759
SIC: 2834 Pharmaceutical Preparations